Skip to main content
null
Albany Law Review
  • Menu
  • Articles
    • General
    • Justice Commentaries
    • New York Appeals
    • State Constitutional Commentary
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Bylaws
  • search

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:25822/feed
General
Vol. 83, Issue 1, 2020January 17, 2020 EDT

BANNING OFF-LABEL DRUG PROMOTION OFFENDS THE U.S. CONSTITUTION: MAKING THE STRONGEST CASE

Lars Noah,
U.S. Food and Drug Administration“off-label” usesapproved therapeutic productsFirst Amendmentcommercial free speech principlesU.S. Supreme Courtbrand-name competitors
Albany Law Review
Lars Noah, BANNING OFF-LABEL DRUG PROMOTION OFFENDS THE U.S. CONSTITUTION: MAKING THE STRONGEST CASE, 83 Albany Law Review (2020).
Save article as...▾

View more stats

This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Powered by Scholastica, the modern academic journal management system